← Leaderboards
Susan Tsai
Univ Of North Carolina Chapel Hill
$1,685,194
Attributed
$4,652,519
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,652,519 · 2
By mechanism
U01$3,846,395 · 1
R01$806,124 · 1
Top collaborators
- Jen Jen Yeh8 shared
- Naim Ur Rashid7 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Jen Jen Yeh$14,819,320
- Ronald I Swanstrom$43,560,887
- Bryce B Reeve$11,567,326
- David N Hayes$17,915,459
- Charles M Perou$46,508,459
Others in their field
Other Emerging Leaders on “Signal Transduction”
- Yunda Huang · Fred Hutchinson Cancer Center$53,064,276
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Leonard Freedman · Leidos Biomedical Research, Inc.$32,575,497
- Bala Raja · Luminostics, Inc.$28,624,460
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
Research focus
Signal TransductionPatient-Focused OutcomesCellsTreatment ResponseResponseTumorTumor SubtypePhosphotransferasesSelection For TreatmentsPrognosticSamplingStandard Of CareClinical TrialsCharacteristicsGenesNeoplastic CellDesmoplasticClia CertifiedHeterogeneityNeoadjuvant TherapyComputing MethodologiesAffectPrediction Of Response To TherapyData Set
Grant awards (8)
Integrating tumor and stroma to understand and predict treatment response$914,890
U01 · FY2025 · CA
Integrating tumor and stroma to understand and predict treatment response$869,831
U01 · FY2024 · CA
Integrating tumor and stroma to understand and predict treatment response$85,780
U01 · FY2024 · CA
Integrating tumor and stroma to understand and predict treatment response$924,643
U01 · FY2023 · CA
Integrating tumor and stroma to understand and predict treatment response$90,295
U01 · FY2023 · CA
Effect of JAK and RIPK2 inhibition on CAF and cancer cell crosstalk$15,050
U01 · FY2023 · CA
Integrating tumor and stroma to understand and predict treatment response$945,906
U01 · FY2022 · CA
Tumor Subtypes and Therapy Response in Pancreatic Cancer$806,124
R01 · FY2021 · CA